<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8-pharmaceutics-11-00040" class="ref">
 <label class="label">8.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Chatziralli</surname>
    <given-names class="given-names">I.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Vlachodimitropoulou</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Daoula</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Vrettou</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Galani</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Theodossiadis</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Theodossiadis</surname>
    <given-names class="given-names">P.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Eplerenone in the treatment of central serous chorioretinopathy: A review of the literature</article-title>
  <source class="source">Int. J. Retin. Vitr.</source>
  <year class="year">2018</year>
  <volume class="volume">4</volume>
  <fpage class="fpage">33</fpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1186/s40942-018-0137-8</pub-id>
  <?supplied-pmid 30250750?>
  <pub-id pub-id-type="pmid" class="pub-id">30250750</pub-id>
 </element-citation>
</ref>
